Lv4
495 积分 2020-09-05 加入
Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trial
21天前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
27天前
已完结
Circulating cytokine profiling and clustering identify biomarker predicting efficacy of ICI in combination with chemotherapy
1个月前
已完结
Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma
3个月前
已完结
PARP Inhibitors Rechallenge in Patients With Recurrent Ovarian Cancer: A Multicentre Real‐World Study in China
3个月前
已完结
Quantifying opportunities to reduce high grade serous ovarian cancer via opportunistic salpingectomy
3个月前
已完结
Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer
3个月前
已完结
The impact of cervical diameter on success of sentinel lymph node mapping in endometrial carcinoma: A retrospective cohort study
3个月前
已完结
Clinical features and prognostic analysis of 247 patients with ovarian clear cell carcinoma (OCCC) and an exploration of the treatment of recurrent OCCC: A single-center study in China
5个月前
已关闭
Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-Grade Serous Tumors with Histologic Transformation
5个月前
已完结
皖公网安备34019202002308
